The drug works great. But the FDA doesn’t want anyone to know that. Why? Because they are corrupt. They will never agree to debate me on that. Steve Kirsch May 16 Summary Fluvoxamine has a systematic review and meta-analysis published in a top medical journal. You cannot get any better than that. It’s the “gold … Read more
OAN Newsroom UPDATED 3:12 PM PT – Tuesday, October 26, 2021 A frontline doctor is hoping to clarify information surrounding COVID-19. One America’s Pearson Sharp has more. Part 1 Part 2 Part 3
Real America – Dan Ball W/ Virologist, Immunologist & Inventor of MRNA Vaccine Technology, Dr. Robert Malone (December 9, 2021)
New Pfizer antiviral and ivermectin, a pharmacodynamic analysis New Pfizer antiviral, PF-07321332, C₂₃H₃₂F₃N₅O₄ PF-07321332 is designed to block the activity of the SARS-CoV-2-3CL protease, https://www.pfizer.com/news/press-rel… So, what is a protease? So what is a protease inhibitor? And, what is 3CL? Chymotrypsin-like protease (3CL main protease, or 3CL Mpro) Identification of SARS-CoV‑2 3CL Protease Inhibitors by … Read more
by Dr. Joseph Mercola October 25, 2021 Editor’s Commentary: Before we get to Dr. Joseph Mercola’s article below, I thought I would offer my two conspiratorial cents on what’s driving Molnupiravir to be released instead of Ivermectin against Covid-19. First and foremost, I do not believe it is as effective as Ivermectin, and that’s the point. They … Read more